Role of ventricular tachycardia cycle length in the outcomes after catheter ablation or antiarrhythmic drugs in the SURVIVE-VT trial

Back

ESC Professional Premium Access

Role of ventricular tachycardia cycle length in the outcomes after catheter ablation or antiarrhythmic drugs in the SURVIVE-VT trial

Session: Sudden cardiac death: insight

Topic: Treatment

Speaker: Doctor P. Avila Alonso (Madrid, ES)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Pablo Avila Alonso

University Hospital Gregorio Maranon, Madrid (Spain)

0 follower

5 more presentations in this session

High incidence of malignant arrhythmias and heart failure in patients with RBM20-associated cardiomyopathy: a multicenter cohort study and review of the literature

Speaker: Mr M. Tukker (Rotterdam, NL)

Significance of J wave with inverted ST-T polarity induced by ill-timed atrial premature beats and its association with Torsade de Pointes in patients with acute acquired long QT syndrome

Speaker: Doctor H. Ichiryu (Gifu, JP)

Comorbidities and use of proarrhythmic drugs in patients with torsade de pointes arrhythmia

Speaker: Doctor K. Nowinski (Stockholm, SE)

Prevalence and characteristics of the catecholamine induced QT prolongation syndrome

Speaker: Professor V. Probst (Nantes, FR)

Identification of genetic variants by using a whole exome sequencing approach in Taiwanese patients with Brugada Syndrome

Speaker: Doctor J. Juang (Taipei, TW)

Access the full session

Sudden cardiac death: insight

Speakers: Doctor P. Avila Alonso, Mr M. Tukker, Doctor H. Ichiryu, Doctor K. Nowinski, Professor V. Probst...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources